Company intelligence / Profile preview

Doppel Farmaceutici

Cortemaggiore, Emilia-Romagna, Italydoppel.it ↗

Ownership: Private
Employees: ~580
Development stage: Commercial

Overview

Doppel Farmaceutici was a leading Italian CDMO specializing in contract research & development and manufacturing for pharmaceutical and nutritional products. It offered formulation development through to commercial batch production for international clients. In July 2024 it merged with Mipharm to create Domixtar Pharmaceuticals.

Modalities: Small moleculeBiologicProteinPeptidesOral solid dosage forms
Industry: Contract Manufacturing Organization

Partnerships

Not specified by name; described as working closely with blue-chip Italian and international pharma/nutraceutical companies

Beyond the preview

Go deeper on Doppel Farmaceutici.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Doppel Farmaceutici.

Explore the full profile